Michael Arman, by Carl O’Donnell (Reuters) – Eli Lilly and co LLY.N On Tuesday, a government-sponsored clinical trial of its COVID-19 antibody treatment similar to the one taken by US President Donald …
Read More »
By John Miller, Carolyn Copley Zurich / Berlin (Reuters) – Countries that rush a second wave of COVID-19 tend toward faster, cheaper but less accurate tests to avoid delays and shortages that …
Read More »
Michael Arman, by Carl O’Donnell (Reuters) – Eli Lilly and co LLY.N On Tuesday, a government-sponsored clinical trial of its COVID-19 antibody treatment similar to the one taken by US President Donald …
Read More »
(Reuters) – Johnson & Johnson JNJ.N On Monday, it said it had temporarily halted its COVID-19 vaccine candidate clinical trials due to an unexplained disease in a study participant, delaying one of …
Read More »
(Reuters) – The US government has awarded a $ 486 million award to AstraZeneca PLC, which developed and protected up to 100,000 doses of COVID-19 antibody treatment, a similar drug was used …
Read More »
File photo A man signs a sign outside the Pfizer headquarters in Manhattan Borough of New York City, New York, US, July 22, 2020. REUTERS / Carlo Allegri (Reuters) – Pfizer Inc. …
Read More »